NCI/Fox Chase Cancer Center Science Writers' Seminar

September 29, 2005

What: National Cancer Institute (NCI) Science Writers' Seminar Series at Fox Chase Cancer Center, Philadelphia, Pa.

How you or a person you love reacts to the news of a cancer diagnosis can be quite different from how another person would react.

Likewise, those at increased risk of developing cancer face a variety of challenges when communicating that risk to other family members and when making decisions about screening strategies.

Please join us for an in-depth look at decision-making and communication when faced with the threat of cancer. The seminar will provide perspective on how family members react to news of a cancer diagnosis when they themselves may also be at risk due to genetic factors; the two distinct ways in which patients respond to news of cancer; and patients' and doctors' differing expectations about participation in cancer clinical trials

The seminar can also be viewed via live and archived Webcast at

Who: Robert C. Young, M.D. (Fox Chase) - President, Fox Chase Cancer Center; Welcome
Michael Stefanek, Ph.D. (NCI) - Integrating basic decision-making into cancer control
Mary Daly, M.D., Ph.D. (Fox Chase) - How women communicate genetic test results
Suzanne Miller, Ph.D. (Fox Chase) "Blunters" and "Monitors"; two patient types who process health information very differently
Neal Meropol, M.D. (Fox Chase) -Apples and oranges: How patients and doctors think about clinical trials

When: Wednesday, October 5, 2005, from 11 a.m. - 1:30 p.m.

Join us for talks that will begin at 11 a.m., followed by a light lunch served at noon. Additional talks and a Q&A session will conclude by 1:30 p.m.

Where: Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia, Pa. 19111.

Seminar will be held in the Lippincott Room. For directions to Fox Chase, go to Free parking is available on campus. Fox Chase is accessible by SEPTA's regional rail line, R8 (; travel time is approximately 30 minutes from 30th St. Station and 25 minutes from 12th and Market St. Amtrak train #185 from New York and train #2104 from Washington, D.C., both arrive into 30th St. Station in time to catch the 10:08 a.m. SEPTA R8 train to Fox Chase. A shuttle will be available for free roundtrip transport between the Fox Chase SEPTA station and the Cancer Center.

How: To register for the press briefing, please contact Dorie Hightower or Ann Benner in the NCI Media Relations Branch at (301) 496-6641 or at

NIH/National Cancer Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to